DICLOFENAC POTASSIUM

Generic: DICLOFENAC POTASSIUM

Aurobindo Pharma LimitedManufacturer
ORALRoute
DICLOFENAC POTASSIUMActive Substance
2021-10-19Original Approval

DICLOFENAC POTASSIUM is FDA application ANDA213875, sponsored by AUROBINDO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
RHEUMATOID ARTHRITIS
2,660 reports
2
FATIGUE
2,540 reports
3
RASH
2,495 reports
4
SYSTEMIC LUPUS ERYTHEMATOSUS
2,490 reports
5
DRUG INEFFECTIVE
2,470 reports
6
OFF LABEL USE
2,469 reports
7
PAIN
2,464 reports
8
JOINT SWELLING
2,416 reports
9
WOUND
2,383 reports
10
PEMPHIGUS
2,316 reports